Shanghai Pharmaceuticals Holding Co's market cap is currently ―. The company's EPS TTM is $0.145; its P/E ratio is 10.33; and it has a dividend yield of 5.71%. Shanghai Pharmaceuticals Holding Co is scheduled to report earnings on April 26, 2024, and the estimated EPS forecast is $0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	¥ 57.37B	¥ 62.90B	¥ 54.81B	¥ 56.90B	¥ 54.85B
Gross Profit	¥ 7.81B	¥ 7.65B	¥ 7.70B	¥ 7.33B	¥ 6.83B
EBIT	¥ 1.70B	¥ 2.20B	¥ 4.20B	¥ 2.39B	¥ 1.75B
EBITDA	¥ 1.70B	¥ 2.20B	¥ 4.20B	¥ 2.39B	¥ 1.75B
Net Income Common Stockholders	¥ 803.25M	¥ 1.12B	¥ 2.44B	¥ 1.25B	¥ 609.24M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	¥ 37.01B	¥ 38.07B	¥ 37.30B	¥ 36.63B	¥ 22.39B
Total Assets	¥ 198.13B	¥ 194.62B	¥ 187.15B	¥ 182.02B	¥ 163.44B
Total Debt	¥ 38.56B	¥ 39.47B	¥ 39.35B	¥ 36.66B	¥ 31.69B
Net Debt	¥ 1.55B	¥ 1.39B	¥ 2.05B	¥ 26.23M	¥ 9.30B
Total Liabilities	¥ 120.13B	¥ 118.00B	¥ 111.43B	¥ 107.64B	¥ 104.37B
Stockholders Equity	¥ 67.06B	¥ 66.17B	¥ 65.33B	¥ 64.52B	¥ 49.36B
Cash Flow	-
Free Cash Flow	¥ 4.17B	¥ -531.69M	¥ 1.49B	¥ -3.07B	¥ -200.30M
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	¥ 1.61B	¥ -2.67B	¥ -10.79B	¥ -631.10M	¥ -1.71B
Financing Cash Flow	¥ -5.02B	¥ 838.13M	¥ -1.28B	¥ 17.59B	¥ -726.11M

Currency in CNY

Shanghai Pharmaceuticals Holding Co Earnings and Revenue History

Income Statement >

Shanghai Pharmaceuticals Holding Co Debt to Assets

Balance Sheet >

Shanghai Pharmaceuticals Holding Co Cash Flow

Cash Flow >

Shanghai Pharmaceuticals Holding Co Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing